Interventional Cardiologist🫀| Alumnus @Georgetown @Mizzou @HMInternalmed @UNTHealth_TCOM @michiganalumni 〽️
Washington, DC
Joined May 2013
- Tweets630
- Following1.1K
- Followers1.2K
- Likes54.7K
Kalyan Chitturi, DO, FACC, FSCAI retweeted
I created LearnCoronary (learncoronary.com), an interactive tool designed to help general cardiology fellows and other early-career learners better understand coronary angiography and the spatial relationships between different angiographic views.
#cardiotwitter @OpenAI
Kalyan Chitturi, DO, FACC, FSCAI retweeted
Review in @CRMjournal provides a comprehensive overview of novel therapies, techniques, and strategies to improve saphenous vein graft longevity after CABG. @wabusnina @KalChitturi @IAmDoctorAbhi @VermaBeniRai @jgalo92 @DorBen @HashimHayder @ronwaksman
sciencedirect.com/science/ar…
Kalyan Chitturi, DO, FACC, FSCAI retweeted
🫀 Countdown to @CRT_meeting – starting March 7th, 2026 🫀
We’re just one week away from the highly anticipated CRT Meeting!!! Looking forward to all the insightful discussions, breakthroughs, and networking opportunities. Don’t miss out! 💯
#Cardiology #CRT2026 #cardiotwitter
Kalyan Chitturi, DO, FACC, FSCAI retweeted
Michigan vs. Duke
No. 1 vs. No. 3
A packed house in Washington DC
let's get it
Kalyan Chitturi, DO, FACC, FSCAI retweeted
Echocardiographic analysis from CMDR demonstrates that cardiac myocardial deformation (strain, diastolic dysfunction, etc.) abnormalities are highly prevalent in patients with ANOCA. @KalChitturi @IlanMerdler @HashimHayder @MedStarResearch @CRT_meeting
sciencedirect.com/science/ar…
Kalyan Chitturi, DO, FACC, FSCAI retweeted
Wow!!!
91M Stuck 1.25mm burr mRCA retrieved with…
GEC ❌
2nd access
➡️ NC ❌
➡️ IVL ❌
➡️ Second rota (!) 1.5mm ❌
➡️ OAS ✅
Audience in shock! Well done Dr Nakao and colleagues 🇯🇵😅 @esbrilakis @DrPeterOKane @DrPrimeroNg @mmamas1973 #TCT2025
Kalyan Chitturi, DO, FACC, FSCAI retweeted
Our recent analysis from CMDR - using the bolus thermodilution technique CFR decreases with advancing age but increased age does not appear to significantly influence the prevalence of CMD or other key microvascular parameters such as IMR and MRR.
pubmed.ncbi.nlm.nih.gov/4090…
📢 Excited to share our latest publication in @CRMjournal!
“DAPT Selection and Duration Before and After PCI: Beyond the Guidelines”
This collaborative effort with leading experts in the field is a deep dive into personalized antiplatelet strategies for PCI patients, going beyond the recently updated 2025 ACC/AHA/SCAI acute coronary syndrome guidelines.
🧠 Thoughtful insights. 💊 Clinical relevance.
📖 Read here: bit.ly/3GncCQ6
Kalyan Chitturi, DO, FACC, FSCAI retweeted
My 1st from #NYValves2025 (and my 1st time at this meeting!):
Surgical explant is associated with better long-term survival compared with redo TAVI in a population of Medicare patients requiring reintervention. @ShinFukuharaMD @DrBowdish @TsuyoshiKaneko1
tctmd.com/news/long-term-sur…
Kalyan Chitturi, DO, FACC, FSCAI retweeted
1/5 ⚠️ Coronary microvascular dysfunction (CMD) significantly raises the risk of adverse cardiovascular outcomes. Detecting CMD accurately is crucial, especially for patients experiencing ANOCA. But what's the best diagnostic method? 🤔💡 @CRMjournal
@KalChitturi @BCase07
Kalyan Chitturi, DO, FACC, FSCAI retweeted
Study protocol in the figure..PROTECT IV is a highly anticipated trial that will impact practice
Q will it be powered for superiority❓@CRMjournal
sciencedirect.com/science/ar…
Kalyan Chitturi, DO, FACC, FSCAI retweeted
I'm thrilled to announce that we've completed randomizing 1252 pts with LVEF <40% and complex CAD to high-risk PCI with Impella CP support vs. control. Now we are in the 1-year follow-up phase and then the results of the PROTECT IV trial will be reported.
Kalyan Chitturi, DO, FACC, FSCAI retweeted
Honored to have co-authored a book chapter together with @IlanMerdler and under the excellent guidance of @ronwaksman
📘 *TAVI and LAAO in High Bleeding Risk Patients: Finding the Right Antithrombotic Strategy*
link.springer.com/chapter/10…
@CRT_meeting
Kalyan Chitturi, DO, FACC, FSCAI retweeted
Pressure-Derived Indices in Left Main Coronary Artery Disease @CircIntv
➡️ PW indices differ significantly between the LAD and LCx in isolated LMCA due to inherent differences in microvascular resistance and coronary flow.
🔗ahajournals.org/doi/10.1161/…
@TheBHF @kingscardio
Kalyan Chitturi, DO, FACC, FSCAI retweeted
Just published in JACC: Cardiovascular Interventions – Image in Intervention: We report the first documented case of Venovo stent migration — a dedicated venous stent. Its design, including edge flaring and connected repeating structural units, posed unique challenges during retrieval.
Operators should be familiar with these technical considerations when planning transcatheter retrieval.
jacc.org/doi/10.1016/j.jcin.…
@JACCJournals
@haberdan @KalChitturi #ItsikBenDor #LowellFSatler @ronwaksman #TobyRogers @keithmhorton #NelsonBernardo
#JACCCI #StentMigration #VenousIntervention
Kalyan Chitturi, DO, FACC, FSCAI retweeted
New consult: Large tissue SAVR at 45 years old followed by large ViV at 50 and now with critical AS and LVEF 25%. I thought that SAVR + ViV TAVR was a 30 year solution...😂. Surgeons, prepare for the tidal wave of these patients coming our way. #Bio4LIFE #fairytale #JustRoss
pubmed.ncbi.nlm.nih.gov/3996…
Kalyan Chitturi, DO, FACC, FSCAI retweeted
Excited 🌟 to share our two recent publications 📄📚from our large health system database at MedStar Washington Hospital Center! 🏥 @MedStarResearch @GTCardFellows @CRT_meeting #cangrelor #cardiology
✅ Gender Disparities in Cangrelor Usage For The Treatment of Patients with ACS undergoing PCI @ccijournal
✅ Lack of Racial Disparities in Cangrelor Therapy in Patients Presenting With ACS Undergoing PCI @IJCardio
Key findings 📊: Women received less Cangrelor and had higher by TIMI major 🩸(no impact on MACE). No racial disparities in use or bleeding risk (AA vs. Caucasian). @ACCinTouch
doi.org/10.1016/j.ijcard.202…
doi.org/10.1002/ccd.31442